MYC and breast cancer: To maintain KSHV latency and oncogenesis, KSHV-latency proteins, LANA and vIRF3, stabilized and activated c-Myc proteins [27–30] and c-Myc was shown to reduce miR-222 expression in mouse mammary tumors [31].